Curtis A. Pettaway
Papers
12
Total Citations
373
H-Index
9
About
Dr. Curtis A. Pettaway is a leading urologic oncologist whose research has fundamentally shaped the modern management of penile and prostate cancers. His most impactful work centers on two key areas: the surgical staging and treatment of penile carcinoma, and the refinement of robotic-assisted surgical techniques. Dr. Pettaway is a pioneer in minimally invasive inguinal lymphadenectomy, demonstrating through a landmark Phase 1 trial (85 citations) and subsequent studies that a robotic approach can dramatically reduce the morbidity of this critical staging procedure while maintaining oncologic efficacy. His comprehensive review on managing penile cancer with lymph node metastasis (101 citations) remains a cornerstone reference for clinicians. In prostate cancer, Dr. Pettaway has been instrumental in standardizing and evaluating training for robot-assisted radical prostatectomy (RARP), using time-based metrics and qualitative grading to objectively assess surgeon proficiency. His work also includes comparative effectiveness research, such as a prospective study on quality of life after brachytherapy versus nerve-sparing RARP (27 citations), and investigations into surgical outcomes in complex salvage and post-radiotherapy settings. With a career dedicated to advancing surgical precision and patient outcomes, Dr. Pettaway’s contributions have set new standards in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1Contemporary management of patients with penile cancer and lymph node metastasis101 citations · 2017
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10